MainboardGMP
LIVE
LIVE GMP
MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·MakeMyTrip (India) Ltd₹0·Sagar Defence Engineering Ltd₹0·Encube Ethicals Ltd₹0·Arjun Jewellers Ltd₹0·Atomberg Technologies Ltd₹0·GNI Infrastructure Ltd₹0·Punjab Carbonic Ltd₹0·Ratnadeep Retail Ltd.₹0·IFL Finance Ltd.₹0·J Pan Tubular Components Ltd₹0·
Home › IPOs › Accretion Nutraveda Ltd › Subscription
AC
Accretion Nutraveda Ltd
CLOSED BSE SME Bookbuilding IPO Fresh Capital Accretion Nutraveda IPO GMP
GREY MARKET PREMIUM
₹ 0
No premium data
EST. LISTING PRICE
₹129
Issue Price: ₹ 129
Back to IPOs Check Allotment Website
Issue Price
₹129
Face Value
₹10
Lot Size
1,000 shares
Open Date
28 Jan 2026
Close Date
30 Jan 2026
Allotment
02 Feb 2026
Listing Date
04 Feb 2026
Exchange
BSE SME

Accretion Nutraveda IPO Details: Price, Dates & Financials

The Accretion Nutraveda IPO GMP strength score is 7.3 out of 10, which the dashboard rates as Good. The Accretion Nutraveda IPO valuation is tagged Good. The Accretion Nutraveda IPO QIB category is reserved for 47.29% of the offer. The Accretion Nutraveda IPO NII/HNI category is reserved for 14.37% of the offer. The Accretion Nutraveda IPO Retail (RII) category is reserved for 33.33% of the offer. Live subscription numbers for the Accretion Nutraveda IPO are not yet available, and amounts are calculated at the upper price band of ₹129.

IPO Analytics Dashboard
LIVE
Accretion Nutraveda IPO GMP Insights
👤
Retail Demand
Good
💼
HNI Interest
Good
🏦
QIB Demand
Strong
📊
Valuation
Good
Accretion Nutraveda IPO GMP Strength Score
7 / 10 Good
0–3 Weak 3–6 Moderate 6–8 Good 8–10 Strong
Accretion Nutraveda IPO Category-wise Subscription Shares offered, bid & amount
Category Sub (x) Offered Bid For
🏦 QIB — 908,000 (47%) —
💼 NII / HNI — 276,000 (14%) —
👤 Retail (RII) — 640,000 (33%) —
📊 Market Maker — 96,000 (5%) —
Σ Total — 1,920,000 (100%) —

* Amount calculated at upper price band (₹129) ·  ** Total includes all investor categories

Subscription Overview Share allocation by investor category
🏦
QIB ? 908,000 (47%)
47%
💼
NII / HNI ? 276,000 (14%)
14%
👤
Retail (RII) ? 640,000 (33%)
33%
📊
Market Maker ? 96,000 (5%)
5%
Total Shares Offered 1,920,000 (100%)
Accretion Nutraveda IPO Application Sizing Minimum investment by category
👤 Retail Investors ?
Min. Lots 2
Shares / Lot 2,000
Min. Investment ₹258,000
💼 HNI Investors ?
Min. Lots 3
Min. Shares 3,000
Min. Investment ₹387,000
Accretion Nutraveda IPO Valuation — EPS & P/E Pre & post-issue metrics
Pre-Issue EPS ?
₹ 5
Post-Issue EPS ?
₹ 6
Pre-Issue P/E ?
26 x
Post-Issue P/E ?
20 x
Accretion Nutraveda IPO Timeline & Key Dates
  1. 1 💳 Initiation of Refund 03 Feb 2026
  2. 2 📂 Credit of Shares to Demat 03 Feb 2026
Investor Interpretation
  • Retail allocation is good at 33% of the total offering.
  • HNI/NII demand is good at 14%.
  • Institutional (QIB) interest is strong at 47%.
  • The IPO P/E of 20x reflects a good valuation relative to typical market ranges.
  • Pre-issue EPS of ₹5 compares to post-issue EPS of ₹6 after dilution.

This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.

✅ Check Allotment Status
Accretion Nutraveda IPO Subscription FAQs
Subscription data for Accretion Nutraveda IPO is not available right now. Numbers are updated here during the bidding window.
In Accretion Nutraveda IPO, retail investors can apply for a minimum of 2 lot(s) (₹₹258,000); HNI/sNII minimum 3 lots (₹₹387,000).
Shares offered by category — QIB 908,000 (47%) shares, Retail 640,000 (33%) shares.
Accretion Nutraveda IPO valuation — pre-issue EPS ₹4.91, post-issue EPS ₹6.44, pre-issue P/E 26.27, post-issue P/E 20.02.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
The NII category covers investors applying for shares outside the retail investor category, while HNI commonly refers to high-value investors within the NII category. Understanding the Accretion Nutraveda IPO's NII and HNI subscription levels helps investors assess demand for the Accretion Nutraveda IPO and overall investor interest.

GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.